201 related articles for article (PubMed ID: 34486917)
1. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
[TBL] [Abstract][Full Text] [Related]
2. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
3. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
[TBL] [Abstract][Full Text] [Related]
5. The differentiation of new human CD303
Zhong Q; Lu Y; Xu W; Rong Z; Chang X; Qin L; Chen X; Zhou F
Int Immunopharmacol; 2021 Oct; 99():107983. PubMed ID: 34298400
[TBL] [Abstract][Full Text] [Related]
6. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
7. Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature.
Jen WY; Konopleva M; Pemmaraju N
Cancer; 2024 Jul; 130(13):2260-2271. PubMed ID: 38620053
[TBL] [Abstract][Full Text] [Related]
8. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell neoplasms.
Lee YJ; Kim Y; Park SH; Jo JC
Blood Res; 2023 Apr; 58(S1):90-95. PubMed ID: 37105563
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis.
Pagliari C; Kanashiro-Galo L; Silva AA; Barboza TC; Criado PR; Duarte MI; Brito AC; Xavier MB; Unger D; Maria Moraes Oliveira C; Quaresma JA; Sotto MN
Med Mycol; 2014 May; 52(4):397-402. PubMed ID: 24782102
[TBL] [Abstract][Full Text] [Related]
12. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2.
Röck J; Schneider E; Grün JR; Grützkau A; Küppers R; Schmitz J; Winkels G
Eur J Immunol; 2007 Dec; 37(12):3564-75. PubMed ID: 18022864
[TBL] [Abstract][Full Text] [Related]
13. Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.
Fournier N; Jacque E; Fontayne A; Derache D; Dupont G; Verhaeghe L; Baptista L; Dehenne A; Dezetter AS; Terrier A; Longue A; Pochet-Beghin V; Beghin C; Chtourou S; de Romeuf C
MAbs; 2018; 10(4):651-663. PubMed ID: 29553870
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
Wu SJ; Sadigh S; Lane AA; Pinkus GS
Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
Adimora IJ; Wilson NR; Pemmaraju N
Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Peng J; He S; Yang X; Huang L; Wei J
Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
[TBL] [Abstract][Full Text] [Related]
19. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling.
Bos S; Poirier-Beaudouin B; Seffer V; Manich M; Mardi C; Desprès P; Gadea G; Gougeon ML
Front Immunol; 2020; 11():582061. PubMed ID: 33193389
[TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm: report of two pediatric cases.
Dharmani PA; Mittal NM; Subramanian PG; Galani K; Badrinath Y; Amare P; Gujral S
Indian J Pathol Microbiol; 2015; 58(1):72-6. PubMed ID: 25673598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
